Rituximab,Methotrexate and Lenalidomide in Newly Diagnosed Primary Central Nervous System Lymphoma

NCT04934579 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Primary Central Nervous System Lymphoma

Interventions

DRUG: Rituximab
DRUG: Lenalidomide
DRUG: Methotrexate

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University